Search Results - "Baid, Rinku"
-
1
Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease
Published in PloS one (31-01-2014)“…Nuclear hormone receptors play a major role in many important biological processes. Most nuclear hormone receptors are ubiquitously expressed and regulate…”
Get full text
Journal Article -
2
LEDGF(1-326) decreases P23H and wild type rhodopsin aggregates and P23H rhodopsin mediated cell damage in human retinal pigment epithelial cells
Published in PloS one (2011)“…P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE) cells are…”
Get full text
Journal Article -
3
Investigating thiol‐modification on hyaluronan via carbodiimide chemistry using response surface methodology
Published in Journal of biomedical materials research. Part A (01-07-2015)“…Hyaluronan (HA) is a naturally occurring glycosaminoglycan widely researched for its use as a biomaterial in tissue engineering, drug delivery, angiogenesis,…”
Get full text
Journal Article -
4
Critical considerations for developing nucleic acid macromolecule based drug products
Published in Drug discovery today (01-03-2016)“…•Increased emphasis in recent years on DNA/mRNA macromolecule-based therapeutic drugs.•Formulation excipients and their role in increasing the drug product…”
Get full text
Journal Article -
5
-
6
Antiapoptotic properties of α-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells
Published in Investigative ophthalmology & visual science (17-04-2013)“…The chaperone proteins, α-crystallins, also possess antiapoptotic properties. The purpose of the present study was to investigate whether 19 to 20-mer…”
Get full text
Journal Article -
7
Critical considerations for developing nucleic acid macromolecule based drug products: Foundation
Published in Drug discovery today (01-03-2016)“…Protein expression therapy using nucleic acid macromolecules (NAMs) as a new paradigm in medicine has recently gained immense therapeutic potential. With the…”
Get full text
Journal Article -
8
Biosynthesis, Characterization, and Efficacy in Retinal Degenerative Diseases of Lens Epithelium-derived Growth Factor Fragment (LEDGF1–326), a Novel Therapeutic Protein
Published in The Journal of biological chemistry (14-06-2013)“…For vision-threatening retinitis pigmentosa and dry age-related macular degeneration, there are no United States Food and Drug Administration (FDA)-approved…”
Get full text
Journal Article -
9
Modifier Genes as Therapeutics: The Nuclear Hormone Receptor Rev Erb Alpha
Published in PloS one (31-01-2014)“…Nuclear hormone receptors play a major role in many important biological processes. Most nuclear hormone receptors are ubiquitously expressed and regulate…”
Get full text
Journal Article -
10
LEDGF.sub.1-326 Decreases P23H and Wild Type Rhodopsin Aggregates and P23H Rhodopsin Mediated Cell Damage in Human Retinal Pigment Epithelial Cells
Published in PloS one (07-09-2011)“…Background P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE)…”
Get full text
Journal Article -
11
Lens epithelium derived growth factor (1-326): A new protein drug for retinal diseases
Published 01-01-2013“…Although over 2.2 million people in the United States suffer from dry age related macular degeneration and retinitis pigmentosa, there are no FDA approved…”
Get full text
Dissertation -
12
LEDGF1-326 Decreases P23H and Wild Type Rhodopsin Aggregates and P23H Rhodopsin Mediated Cell Damage in Human Retinal Pigment Epithelial Cells
Published in PloS one (07-09-2011)“…Background P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE)…”
Get full text
Journal Article